Earlier this year, the largest tobacco company in the world paid millions to fund continuing medical education courses on nicotine addiction —16,000 physicians and other health care providers took them.
Category: Digitally Driven
A horse-saving procedure fuels Kentucky Derby dreams
An experimental technology developed by Stanford Medicine bioengineers saves the life of a precious racehorse with big-league dreams.
These are the tools for providing top-notch diabetes care to everyone
Using AI, continuous glucose monitors, and an equity approach, diabetes care could be saving many more lives, Stanford Medicine researchers say.
Inequity of genetic screening: DNA tests fail non-white families more often
Research is showing that advanced methods of genetic testing aren’t equally useful for everyone: They’re less accurate for non-white families, raising concerns about how historical gaps in whose DNA gets studied produce inequities in medical care.
Could anesthesia-induced dreams wipe away trauma?
Cases of patients who recovered from trauma after dreaming under surgical anesthesia spur Stanford Medicine researchers to investigate dreaming as therapy.
Serious talk about moods with bipolar disorder expert Po Wang
Often misunderstood and undertreated, bipolar disorder has received close attention from Stanford Medicine clinicians and researchers for more than 30 years.
Large language models in the clinic: AI enters the physician-patient mix
Stanford Medicine doctors and researchers are modifying existing chatbots to perform well in a frontier of AI-enhanced medicine: the doctor-patient interaction.
Match Day 101: How does the medical residency match work?
Graduating medical students go through an unusual springtime ritual known as Match Day to find out where they’ll continue their training. Here’s everything you wanted to know about the big day.
One step back: Why the new Alzheimer’s plaque-attack drugs don’t work
A few closely related drugs, all squarely aimed at treating Alzheimer’s disease, have served up what can be charitably described as a lackadaisical performance. Stanford Medicine neurologist Mike Greicius explains why these drugs, so promising in theory, don’t appear to be helping patients much if at all.
What really happens to our memory as we age?
A Q&A with a Stanford neuroscientist on dementia, healthy aging and memory loss — and how we can protect our brains in later life.
PA student, a cancer survivor, rolls with the punches
She was a first-year PA student at Stanford Medicine when an MRI scan revealed that Melanie Shojinaga had a brain tumor.
Researchers dial in on genetic culprit of disease
Genome-wide association studies can lay the groundwork to more precisely assess a person’s risk for disease, detect diseases earlier, reveal a molecular understanding of how certain illnesses arise, and point to new therapeutic targets.
For those with an alcohol problem, are non-alcoholic beverages a wise choice?
Q&A with a Stanford addiction specialist on whether non-alcoholic beverages are helpful or harmful for those with alcohol use disorders
How the death of his wife drives data scientist to improve the system
In his grief over losing his wife, Amir Bahmani realized how much data science could impact medicine and potentially save lives.
At the intersection of science and humanity, he found a sweet spot
Medicine has been the way of connecting both of Brian Smith's passions. “With medicine I could have the intellectual curiosity, but also the chance to talk with people and enjoy the human experience.”
New cardiovascular risk calculator includes social determinants of health, excludes race
Many social determinants of health can influence a patient’s risk, but Palaniappan and fellow researchers have noticed, from working with data from patients around the nation, that race is not among the most accurate or equitable.